These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 13725917)

  • 21. [POLIOMYELITIS IN THE CHILD. REFERENCES TO VIROLOGICAL FINDINGS].
    GONZALEZ M; SCROGGIE S; DIAZ R
    Rev Chil Pediatr; 1964 Jan; 35():24-8. PubMed ID: 14163294
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].
    Blondel B; Autret A; Brisac C; Pelletier I; Martin-Latil S; Jegouic S; Bessaud M; Joffret ML; Balanant J; Colbère-Garapin F; Delpeyroux F
    Med Trop (Mars); 2008 Apr; 68(2):189-202. PubMed ID: 18630055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 24. Community spread of orally administered attenuated poliovirus vaccine strains.
    KIMBALL AC; BARR RN; BAUERH ; KLEINMANH ; JOHNSON EA; COONEY MK
    Public Health Rep (1896); 1961 Oct; 76(10):903-14. PubMed ID: 14455990
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of the effect of vaccination with live poliomyelitis vaccine on the circulation of enteroviruses in the population.
    Tarabcák M; Kratochvil I; Milosovicová A
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(3):258-66. PubMed ID: 4329049
    [No Abstract]   [Full Text] [Related]  

  • 28. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine.
    JUNGHERR EL; CABASSO VJ; MOYER AW; COX HR
    J Infect Dis; 1961; 108():247-61. PubMed ID: 13791071
    [No Abstract]   [Full Text] [Related]  

  • 29. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties and behavior of orally administered attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1957 Jul; 164(11):1216-23. PubMed ID: 13438685
    [No Abstract]   [Full Text] [Related]  

  • 32. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 33. [VIROLOGICAL STUDIES ON 2 PATIENTS WITH PARESIS IN CHRONOLOGICAL RELATION TO VACCINATION WITH ORAL POLIOVACCINE IN APRIL-MAY 1963].
    HAHNEMANN F; SIBONI K; GODTFREDSEN A; VON MAGNUS
    Fra Sundhedsstyr; 1963 Oct; 125():72-3. PubMed ID: 14095905
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy of polio vaccination in Finland.
    Lapinleimu K; Stenvik M
    Dev Biol Stand; 1978; 41():137-9. PubMed ID: 223906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 36. IN VITRO MARKER OF POLIOVIRUSES OBTAINED FROM HUMAN STOOLS AFTER ADMINISTRATION OF ATTENUATED LIVE POLIOVIRUS VACCINE (SABIN).
    KASAHARA S; YOSHIOKA I; YAMAGISHI H; AIZAWA C
    Kitasato Arch Exp Med; 1963 Dec; 36():77-86. PubMed ID: 14318783
    [No Abstract]   [Full Text] [Related]  

  • 37. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 40. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.